Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02115282
Title Entinostat in Patients With Recurrent Advanced Hormone Receptor-Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)

estrogen-receptor positive breast cancer

progesterone-receptor positive breast cancer


Exemestane + Goserelin

Entinostat + Exemestane + Goserelin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.